Additional information
| Active substance | Pyridostigmine Bromide |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of cholinesterase levels may be conducted to assess efficacy and dosage requirements |
| Also known as | Mestinon, Regonol |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause fluctuations, typically lowering blood pressure due to vasodilation |
| Trade name | Mestinon, Regonol |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 3-hydroxy-1-methylpyridinium bromide dimethylcarbamate |
| Formula | C9H13BrN2O2 |
| Substance class | Acetylcholinesterase inhibitor |
| Main action | Inhibits the breakdown of acetylcholine, thereby increasing its concentration at neuromuscular junctions |
| Half-life | Approximately 1.78 to 2.25 hours |
| Dosage (medical) | Typical starting dose for adults in the treatment of myasthenia gravis is 60 mg taken orally every 4 hours but can vary based on individual patient needs and conditions |
| Dosage (sports) | Not applicable as it is not legally used to enhance athletic performance |
| Effects | Improved muscle strength in patients with myasthenia gravis |
| Side effects | Nausea, vomiting, diarrhea, abdominal cramps, increased salivation and sweating, muscle cramps, and twitching |
| Use in sports | Not used or recommended |
| Manufacturer | Meda Pharma |
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim
AVELOX 400 Bayer
Zyban Glaxosmithkline
Spiriva HandiHaler 18mg Boehringer Ingelheim
Zimaks 400 Bilim
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
LACIPIL 4 mg Glaxosmithkline
Champix 56 tabs Pfizer
SOMATROX XT LABS
Norvacs 10 mg Pfizer
Champix Starter Pack Pfizer
Prograf 5mg Astellas Pharma 

Reviews
There are no reviews yet.